{
    "name": "niraparib",
    "comment": "Rx",
    "other_names": [
        "Zejula"
    ],
    "classes": [
        "Antineoplastics",
        "PARP Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/zejula-niraparib-1000146",
    "pregnancy": {
        "common": [
            "Niraparib has the potential to cause teratogenicity and/or embryo-fetal death since niraparib is genotoxic and targets actively dividing cells in animals and patients (eg, bone marrow)",
            "A pregnancy test is recommended for females of reproductive potential prior to initiating drug",
            "Based on animal studies, may impair fertility in males of reproductive potential"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Advise females of reproductive potential to use effective contraception during treatment for at least 6 months following the last dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data are available regarding the presence of niraparib or its metabolites in human milk, or on its effects on the breastfed infant or milk production",
            "Owing to the potential for serious adverse reactions in breastfed infants, advise a lactating woman not to breastfeed during treatment and for 1 month after receiving the final dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Myelodysplastic syndrome/acute myeloid leukemia (MDS/AML), including cases with fatal outcome, reported; for suspected MDS/AML or prolonged hematological toxicities, refer the patient to a hematologist for further evaluation; discontinue drug if MDS/AML confirmed",
                "Hypertension and hypertensive crisis reported; monitor BP and HR monthly for the first year and periodically thereafter during treatment; medically manage hypertension with antihypertensive medications and niraparib dose adjustment",
                "Capsules contain FD&C Yellow No. 5 (tartrazine), which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons; incidence of sensitivity in the general population is low, frequently seen in patients who also have aspirin hypersensitivity",
                "Based on its mechanism of action, can cause fetal harm if administered to a pregnant woman (see Pregnancy)"
            ],
            "specific": [
                {
                    "type": "Encephalopathy syndrome",
                    "description": [
                        "Posterior reversible encephalopathy syndrome (PRES) reported; signs and symptoms of PRES include seizure, headache, altered mental status, visual disturbance, or cortical blindness, with or without associated hypertension",
                        "A diagnosis of PRES requires confirmation by brain imaging, preferably magnetic resonance imaging",
                        "Monitor all patients receiving treatment for signs and symptoms of PRES; if PRES is suspected, promptly discontinue drug and administer appropriate treatment",
                        "The safety of reinitiating treatment in patients previously experiencing PRES not known"
                    ]
                },
                {
                    "type": "Bone marrow suppression",
                    "description": [
                        "May cause bone marrow suppression resulting in hematologic toxicities (eg, thrombocytopenia, anemia, neutropenia)",
                        "Do not initiate until patients have recovered from hematological toxicities caused by previous chemotherapy (grade â‰¤1)",
                        "Monitor complete blood cell counts weekly for the first month, monthly for the next 11 months of treatment, and periodically after this time (also see Dosage Modifications)"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Adverse effects include all grades unless otherwise stated",
            "percent": "74"
        },
        {
            "name": "Nausea",
            "percent": "61"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "57"
        },
        {
            "name": "Fatigue",
            "percent": "55"
        },
        {
            "name": "asthenia",
            "percent": "50"
        },
        {
            "name": "Fatigue",
            "percent": "40"
        },
        {
            "name": "Anemia",
            "percent": "36"
        },
        {
            "name": "Constipation",
            "percent": "34"
        },
        {
            "name": "Musculoskeletal pain",
            "percent": "33"
        },
        {
            "name": "Vomiting",
            "percent": "30"
        },
        {
            "name": "Abdominal pain",
            "percent": "3"
        },
        {
            "name": "distention",
            "percent": "4"
        },
        {
            "name": "Neutropenia",
            "percent": "29"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "27"
        },
        {
            "name": "grades",
            "percent": "26"
        },
        {
            "name": "or",
            "percent": "3"
        },
        {
            "name": "Insomnia",
            "percent": "4"
        },
        {
            "name": "Headache",
            "percent": "25"
        },
        {
            "name": "Anemia",
            "percent": "24"
        },
        {
            "name": "grades",
            "percent": "23"
        },
        {
            "name": "or",
            "percent": "21"
        },
        {
            "name": "Decreased appetite",
            "percent": "20"
        },
        {
            "name": "Nasopharyngitis",
            "percent": "3"
        },
        {
            "name": "Rash",
            "percent": "4"
        },
        {
            "name": "Hypertension",
            "percent": "20"
        },
        {
            "name": "Neutropenia",
            "percent": "20"
        },
        {
            "name": "grades",
            "percent": "20"
        },
        {
            "name": "or",
            "percent": "20"
        },
        {
            "name": "Mucositis",
            "percent": "19"
        },
        {
            "name": "stomatitis",
            "percent": "18"
        },
        {
            "name": "Diarrhea",
            "percent": "18"
        },
        {
            "name": "Dyspepsia",
            "percent": "18"
        },
        {
            "name": "Myalgia",
            "percent": "17"
        },
        {
            "name": "Back pain",
            "percent": "16"
        },
        {
            "name": "Dyspepsia",
            "percent": "13"
        },
        {
            "name": "Dizziness",
            "percent": "13"
        },
        {
            "name": "Leukopenia",
            "percent": "13"
        },
        {
            "name": "Cough",
            "percent": "11"
        },
        {
            "name": "Acute kidney injury",
            "percent": "11"
        },
        {
            "name": "UTI",
            "percent": "10"
        },
        {
            "name": "Arthralgia",
            "percent": "10"
        },
        {
            "name": "Anxiety",
            "percent": "10"
        },
        {
            "name": "Hypomagnesemia",
            "percent": "10"
        },
        {
            "name": "Palpitations",
            "percent": "3"
        },
        {
            "name": "Dry mouth",
            "percent": "4"
        },
        {
            "name": "AST",
            "percent": "9"
        },
        {
            "name": "ALT elevation",
            "percent": "3"
        },
        {
            "name": "Dysgeusia",
            "percent": "4"
        },
        {
            "name": "Hypertension",
            "percent": "5"
        },
        {
            "name": "grade",
            "percent": null
        },
        {
            "name": "or",
            "percent": null
        },
        {
            "name": "Leukopenia",
            "percent": null
        },
        {
            "name": "grades",
            "percent": null
        },
        {
            "name": "or",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Hypersensitivity",
            "percent": null
        },
        {
            "name": "including anaphylaxis",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Posterior reversible encephalopathy syndrome",
            "percent": null
        },
        {
            "name": "PRES",
            "percent": null
        },
        {
            "name": "Psychiatric disorders",
            "percent": null
        },
        {
            "name": "Confusional state",
            "percent": null
        },
        {
            "name": "disorientation",
            "percent": null
        },
        {
            "name": "hallucination",
            "percent": null
        },
        {
            "name": "cognitive impairment",
            "percent": null
        },
        {
            "name": "eg",
            "percent": null
        },
        {
            "name": "memory impairment",
            "percent": null
        },
        {
            "name": "concentration impairment",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic",
            "percent": null
        },
        {
            "name": "and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Non",
            "percent": null
        },
        {
            "name": "infectious pneumonitis",
            "percent": null
        },
        {
            "name": "Skin and SC tissue disorders",
            "percent": null
        },
        {
            "name": "Photosensitivity",
            "percent": null
        },
        {
            "name": "Hematologic disorders",
            "percent": null
        },
        {
            "name": "Neutropenic infection",
            "percent": null
        },
        {
            "name": "neutropenic sepsis",
            "percent": null
        },
        {
            "name": "febrile neutropenia",
            "percent": null
        },
        {
            "name": "pancytopenia",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Hypertensive crisis",
            "percent": null
        }
    ]
}